Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Jun;102(Suppl 2):145–153. doi: 10.1289/ehp.94102145

Developmental neurotoxicity induced by therapeutic and illicit drugs.

C V Vorhees 1
PMCID: PMC1567091  PMID: 7925185

Abstract

The developmental neurotoxicity of phenytoin, isotretinoin, and methamphetamine has been reviewed to illustrate effects from both therapeutic and illicit drugs to which people are exposed and which either induce or show the potential for inducing learning disabilities following in utero exposure. In each case both human and experimental animal data are presented and compared where possible. The findings point to several conclusions. First, some drugs in current use induce developmental neurotoxicity, and it cannot safely be assumed that there are not more as yet unidentified. Second, of the types of neurotoxicity induced by drugs, learning disabilities figure prominently. Third, the effects observed are dependent on both the drug's mechanism of action and the period of brain development during which exposure occurs. Fourth, with the exception of CNS teratogens, it is not yet possible to predict which periods of brain development are the most vulnerable for the induction of learning disabilities, as seen by the different patterns of critical periods for phenytoin and isotretinoin compared to methamphetamine. Fifth, as seen with isotretinoin, existing drugs that cause developmental neurotoxicity are not the only problem; new drugs with such effects are still being introduced. Sixth, only a small fraction of the drugs currently in use have ever been examined for developmental neurotoxicity; hence, the full scope of the problem cannot even be accurately estimated based on current information. It is concluded that prevention of new cases caused by drugs such as isotretinoin should be a high priority for future regulatory action.

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acuff-Smith K. D., George M., Lorens S. A., Vorhees C. V. Preliminary evidence for methamphetamine-induced behavioral and ocular effects in rat offspring following exposure during early organogenesis. Psychopharmacology (Berl) 1992;109(3):255–263. doi: 10.1007/BF02245871. [DOI] [PubMed] [Google Scholar]
  2. Adams J. Ultrasonic vocalizations as diagnostic tools in studies of developmental toxicity: an investigation of the effects of hypervitaminosis A. Neurobehav Toxicol Teratol. 1982 May-Jun;4(3):299–304. [PubMed] [Google Scholar]
  3. Butcher R. E., Brunner R. L., Roth T., Kimmel C. A. A learning impairment associated with maternal hypervitaminosis-A in rats. Life Sci I. 1972 Feb 1;11(3):141–145. doi: 10.1016/0024-3205(72)90227-5. [DOI] [PubMed] [Google Scholar]
  4. Coyle I. R., Singer G. The interaction of post-weaning housing conditions and prenatal drug effects on behaviour. Psychopharmacologia. 1975;41(3):237–244. doi: 10.1007/BF00428930. [DOI] [PubMed] [Google Scholar]
  5. DiLiberti J. H., Farndon P. A., Dennis N. R., Curry C. J. The fetal valproate syndrome. Am J Med Genet. 1984 Nov;19(3):473–481. doi: 10.1002/ajmg.1320190308. [DOI] [PubMed] [Google Scholar]
  6. Dixon S. D., Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr. 1989 Nov;115(5 Pt 1):770–778. doi: 10.1016/s0022-3476(89)80661-4. [DOI] [PubMed] [Google Scholar]
  7. Elmazar M. M., Sullivan F. M. Effect of prenatal phenytoin administration on postnatal development of the rat: a behavioral teratology study. Teratology. 1981 Oct;24(2):115–124. doi: 10.1002/tera.1420240202. [DOI] [PubMed] [Google Scholar]
  8. Hanson J. W., Smith D. W. The fetal hydantoin syndrome. J Pediatr. 1975 Aug;87(2):285–290. doi: 10.1016/s0022-3476(75)80604-4. [DOI] [PubMed] [Google Scholar]
  9. Hill R. M., Verniaud W. M., Horning M. G., McCulley L. B., Morgan N. F. Infants exposed in utero to antiepileptic drugs. A prospective study. Am J Dis Child. 1974 May;127(5):645–653. doi: 10.1001/archpedi.1974.02110240031002. [DOI] [PubMed] [Google Scholar]
  10. Hutchings D. E., Gaston J. The effects of vitamin A excess administered during the mid-fetal period on learning and development in rat offspring. Dev Psychobiol. 1974 May;7(3):225–233. doi: 10.1002/dev.420070306. [DOI] [PubMed] [Google Scholar]
  11. Hutchings D. E., Gibbon J., Kaufman M. A. Maternal vitamin A excess during the early fetal period: effects on learning and development in the offspring. Dev Psychobiol. 1973 Sep;6(5):445–457. doi: 10.1002/dev.420060509. [DOI] [PubMed] [Google Scholar]
  12. Jones K. L., Lacro R. V., Johnson K. A., Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med. 1989 Jun 22;320(25):1661–1666. doi: 10.1056/NEJM198906223202505. [DOI] [PubMed] [Google Scholar]
  13. Kutz S. A., Troise N. J., Cimprich R. E., Yearsley S. M., Rugen P. J. Vitamin A acetate: a behavioral teratology study in rats. Drug Chem Toxicol. 1989 Sep-Dec;12(3-4):259–275. doi: 10.3109/01480548908999157. [DOI] [PubMed] [Google Scholar]
  14. Lammer E. J., Chen D. T., Hoar R. M., Agnish N. D., Benke P. J., Braun J. T., Curry C. J., Fernhoff P. M., Grix A. W., Jr, Lott I. T. Retinoic acid embryopathy. N Engl J Med. 1985 Oct 3;313(14):837–841. doi: 10.1056/NEJM198510033131401. [DOI] [PubMed] [Google Scholar]
  15. Little B. B., Snell L. M., Gilstrap L. C., 3rd Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol. 1988 Oct;72(4):541–544. [PubMed] [Google Scholar]
  16. Meadow S. R. Anticonvulsant drugs and congenital abnormalities. Lancet. 1968 Dec 14;2(7581):1296–1296. doi: 10.1016/s0140-6736(68)91781-9. [DOI] [PubMed] [Google Scholar]
  17. Minck D. R., Acuff-Smith K. D., Vorhees C. V. Comparison of the behavioral teratogenic potential of phenytoin, mephenytoin, ethotoin, and hydantoin in rats. Teratology. 1991 Apr;43(4):279–293. doi: 10.1002/tera.1420430402. [DOI] [PubMed] [Google Scholar]
  18. Morris R. G., Garrud P., Rawlins J. N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 1982 Jun 24;297(5868):681–683. doi: 10.1038/297681a0. [DOI] [PubMed] [Google Scholar]
  19. Nolen G. A. The effects of prenatal retinoic acid on the viability and behavior of the offspring. Neurobehav Toxicol Teratol. 1986 Nov-Dec;8(6):643–654. [PubMed] [Google Scholar]
  20. Oro A. S., Dixon S. D. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987 Oct;111(4):571–578. doi: 10.1016/s0022-3476(87)80125-7. [DOI] [PubMed] [Google Scholar]
  21. Rudd N. L., Freedom R. M. A possible primidone embryopathy. J Pediatr. 1979 May;94(5):835–837. doi: 10.1016/s0022-3476(79)80173-0. [DOI] [PubMed] [Google Scholar]
  22. Saillenfait A. M., Vannier B. Methodological proposal in behavioural teratogenicity testing: assessment of propoxyphene, chlorpromazine, and vitamin A as positive controls. Teratology. 1988 Mar;37(3):185–199. doi: 10.1002/tera.1420370303. [DOI] [PubMed] [Google Scholar]
  23. Smith D. W. Teratogenicity of anticonvulsive medications. Am J Dis Child. 1977 Dec;131(12):1337–1339. doi: 10.1001/archpedi.1977.02120250019001. [DOI] [PubMed] [Google Scholar]
  24. Vanoverloop D., Schnell R. R., Harvey E. A., Holmes L. B. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol. 1992 Sep-Oct;14(5):329–335. doi: 10.1016/0892-0362(92)90039-d. [DOI] [PubMed] [Google Scholar]
  25. Vorhees C. V., Brunner R. L., Butcher R. E. Psychotropic drugs as behavioral teratogens. Science. 1979 Sep 21;205(4412):1220–1225. doi: 10.1126/science.472738. [DOI] [PubMed] [Google Scholar]
  26. Vorhees C. V., Brunner R. L., McDaniel C. R., Butcher R. E. The relationship of gestational age to vitamin A induced postnatal dysfunction. Teratology. 1978 Jun;17(3):271–275. doi: 10.1002/tera.1420170305. [DOI] [PubMed] [Google Scholar]
  27. Vorhees C. V., Minck D. R. Long-term effects of prenatal phenytoin exposure on offspring behavior in rats. Neurotoxicol Teratol. 1989 May-Jun;11(3):295–305. doi: 10.1016/0892-0362(89)90072-x. [DOI] [PubMed] [Google Scholar]
  28. Zackai E. H., Mellman W. J., Neiderer B., Hanson J. W. The fetal trimethadione syndrome. J Pediatr. 1975 Aug;87(2):280–284. doi: 10.1016/s0022-3476(75)80603-2. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES